作者：
Laura,Fouassier [1]
;
Marco,Marzioni [2]
;
Marta B,Afonso [3]
;
Steven,Dooley [4]
;
Kevin,Gaston [5]
;
Gianluigi,Giannelli [6]
;
Cecilia M P,Rodrigues [3]
;
Elisa,Lozano [7]
;
Serena,Mancarella [6]
;
Oreste,Segatto [8]
;
Javier,Vaquero [1]
;
Jose J G,Marin [9]
;
Cédric,Coulouarn [7]
作者单位：
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
[1]
Clinic of Gastroenterology and Hepatology, Università Politecnica delle Marche, Ospedali Riuniti - University Hospital, Ancona, Italy.
[2]
Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal.
[3]
Department of Medicine II, Molecular Hepatology Section, Heidelberg University, Mannheim, Germany.
[4]
Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
[5]
National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, Bari, Italy.
[6]
Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
[7]
Unit of Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
[8]
Sorbonne Université, CNRS, Ecole Polytech., Univ. Paris-Sud, Observatoire de Paris, Université Paris-Saclay, PSL Research University, Paris, France.
[9]
Inserm, Univ Rennes, Inra, Institut NuMeCan (Nutrition Metabolisms and Cancer), Rennes, France.
[10]
DOI
10.1111/liv.14102
PMID
30903728
发布时间
2020-01-15
换一批
换一批
